본문 바로가기
KERD
논문KCI 등재

Can proton pump inhibitors reduce rebleeding following Histoacryl sclerotherapy for gastric variceal hemorrhage?

김현수|박선영|유종선|주영은|최성규|박창환|전충환|위진우|조성범|조규만|이완식|김가람
대한내과학회 (The Korean Association Of Internal Medicine)|2015.09|The Korean Journal of Internal Medicine|제30권 제5호|pp. 593-601|DOI http://dx.doi.org/10.3904/kjim.2015.30.5.593

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

Treatment outcomeHemostasisProton pump inhibitorsEndoscopicEsophageal and gastric varicesCyanoacrylates
주제분류내과학

초록

Background/Aims: To evaluate the efficacy of proton pump inhibitors (PPIs) in reducing rebleeding and bleeding-related death rates after endoscopic gastric variceal obliteration (GVO) using N-butyl-2-cyanoacrylate (NBC). Methods: This study enrolled 341 patients who were consecutively diagnosed with and treated for bleeding gastric varices. The patients were divided into PPI and non-PPI groups, and their endoscopic findings, initial hemostasis outcomes, rebleeding and bleeding-related death rates, and treatment-related complications were analyzed. Results: The rate of initial hemostasis was 97.1%. rebleeding occurred in 2.2% of patients within 2 weeks, 3.9% of patients within 4 weeks, 18.9% of patients within 6 months, and 27.6% of patients within 12 months of the GVO procedure. A previous history of variceal bleeding (relative risk [RR], 1.955; 95% confidence interval [CI], 1.263 to 3.028; p = 0.003) and use of PPIs (RR, 0.554; 95% CI, 0.352 to 0.873; p = 0.011) were associated with rebleeding. Child-Pugh class C (RR, 10.914; 95% CI, 4.032 to 29.541; p < 0.001), failure of initial hemostasis (RR, 13.329; 95% CI, 2.795 to 63.556; p = 0.001), and the presence of red-colored concomitant esophageal varices (RR, 4.096; 95% CI, 1.320 to 12.713; p = 0.015) were associated with bleeding-related death. Conclusions: The prophylactic use of PPIs reduces rebleeding after GVO using NBC in patients with gastric variceal hemorrhage. However, prophylactic use of PPIs does not reduce bleeding-related death.

Abstract

Background/Aims: To evaluate the efficacy of proton pump inhibitors (PPIs) in reducing rebleeding and bleeding-related death rates after endoscopic gastric variceal obliteration (GVO) using N-butyl-2-cyanoacrylate (NBC). Methods: This study enrolled 341 patients who were consecutively diagnosed with and treated for bleeding gastric varices. The patients were divided into PPI and non-PPI groups, and their endoscopic findings, initial hemostasis outcomes, rebleeding and bleeding-related death rates, and treatment-related complications were analyzed. Results: The rate of initial hemostasis was 97.1%. rebleeding occurred in 2.2% of patients within 2 weeks, 3.9% of patients within 4 weeks, 18.9% of patients within 6 months, and 27.6% of patients within 12 months of the GVO procedure. A previous history of variceal bleeding (relative risk [RR], 1.955; 95% confidence interval [CI], 1.263 to 3.028; p = 0.003) and use of PPIs (RR, 0.554; 95% CI, 0.352 to 0.873; p = 0.011) were associated with rebleeding. Child-Pugh class C (RR, 10.914; 95% CI, 4.032 to 29.541; p < 0.001), failure of initial hemostasis (RR, 13.329; 95% CI, 2.795 to 63.556; p = 0.001), and the presence of red-colored concomitant esophageal varices (RR, 4.096; 95% CI, 1.320 to 12.713; p = 0.015) were associated with bleeding-related death. Conclusions: The prophylactic use of PPIs reduces rebleeding after GVO using NBC in patients with gastric variceal hemorrhage. However, prophylactic use of PPIs does not reduce bleeding-related death.

참고문헌 (24)

  1. Sarin SK, "Gastric varices: profile, classification, and management", Am J Gastroenterol, 84, pp.1244~1249 (1989)
  2. Watanabe K, "Portal hemodynamics in patients with gastric varices: a study in 230 patients with esophageal and", or gastric varices using portal vein catheterization, 1988, pp.95, 434~440
  3. Sarin SK, "Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients", Hepatology, 16, pp.1343~1349 (1992)
  4. Sarin SK., "Long-term follow-up of gastric variceal sclerotherapy:an eleven-year experience", Gastrointest Endosc, 46, pp.8~14 (1997)
  5. Garcia-Tsao G, "Practice Guidelines Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis", Hepatology, 46, pp.922~938 (2007)
  6. Huang YH, "Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety", Gastrointest Endosc, 52, pp.160~167 (2000)
  7. Mumtaz K, "Prevalence of gastric varices and results of sclerotherapy with N-butyl 2 cyanoacrylate for controlling acute gastric variceal bleeding", World J Gastroenterol, 13, pp.1247~1251 (2007)
  8. Fry LC, "Efficacy, complications and clinical outcomes of endoscopic sclerotherapy with N-butyl-2-cyanoacrylate for bleeding gastric varices", Dig Dis, 26, pp.300~303 (2008)
  9. Oho K, "Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study", Endoscopy, 27, pp.349~354 (1995)
  10. Akahoshi T, "Longterm results of endoscopic Histoacryl injection sclerotherapy for gastric variceal bleeding: a 10-year experience", Surgery, 131(1 Suppl), pp.S176~S181 (2002)
  11. Park WG, "Triadafilopoulos G. Injection therapies for variceal bleeding disorders of the GI tract", Gastrointest Endosc, 67, pp.313~323 (2008)
  12. Kok K, "Distal embolization and local vessel wall ulceration after gastric variceal obliteration with N-butyl-2-cyanoacrylate: a case report and review of the literature", Endoscopy, 36, pp.442~446 (2004)
  13. Gimson A, "Omeprazole in the management of intractable esophageal ulceration following injection sclerotherapy", Gastroenterology, 99, pp.1829~1831 (1990)
  14. Shaheen NJ, "Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial", Hepatology, 41, pp.588~594 (2005)
  15. Hidaka H, "Long-term administration of PPI reduces treatment failures after esophageal variceal band ligation: a randomized, controlled trial", J Gastroenterol, 47, pp.118~126 (2012)
  16. de Franchis R, "Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension", J Hepatol, 53, pp.762~768 (2010)
  17. Hashizume M, "Endoscopic classification of gastric varices", Gastrointest Endosc, 36, pp.276~280 (1990)
  18. Tan PC, "A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage:N-butyl-2-cyanoacrylate injection versus band ligation", Hepatology, 43, pp.690~697 (2006)
  19. de Franchis R, "Natural history of portal hypertension in patients with cirrhosis", Clin Liver Dis, 5, pp.645~663 (2001)
  20. Trudeau W, "Endoscopic injection sclerosis in bleeding gastric varices", Gastrointest Endosc, 32, pp.264~268 (1986)
  21. Arakawa M, "Pathomorphology of esophageal and gastric varices", Semin Liver Dis, 22, pp.73~82 (2002)
  22. Toriumi DM, "Variable histotoxicity of histoacryl when used in a subcutaneous site: an experimental study", Laryngoscope, 101(4Pt 1), pp.339~343 (1991)
  23. Kind R, "Bucrylate treatment of bleeding gastric varices: 12 years’ experience", Endoscopy, 32, pp.512~519 (2000)
  24. Kim T, "Risk factors for hemorrhage from gastric fundal varices", Hepatology, 25, pp.307~312 (1997)

관련 논문AI추천

The secondary prophylactic efficacy of beta-blocker after endoscopic gastric variceal obturation for first acute episode of gastric variceal bleeding김민진, 김부성, 김상균, 김영석, 김홍수, 서유리, 이세환, 이윤나, 장재영, 정승원, 최문한대한간학회 · Clinical and Molecular Hepatology2013 · 제19권 제3호Cyanoacrylate injection versus band ligation for bleeding from cardiac varices along the lesser curvature of the stomach김용권, 김지훈, 김태형, 박상정, 박승운, 변관수, 서상준, 서연석, 안형인, 엄순호, 연종은, 이한아, 임형준, 장재영, 정영걸대한간학회 · Clinical and Molecular Hepatology2016 · 제22권 제4호Emergency endoscopic variceal ligation in cirrhotic patients with blood clots in the stomach but no active bleeding or stigmata increases the risk of rebleeding조몽, 강대환, 김수진, 김형욱, 남형석, 박수범, 윤기태, 최철웅, 홍영미, SM Bakhtiar UI Islam대한간학회 · Clinical and Molecular Hepatology2016 · 제22권 제4호Evaluation of Treatment Response after Endoscopic Variceal Obturation with Abdominal Computed TomographyChang Duck Kim, Eun Sun Kim, Han Ah Lee, Hoon Jai Chun, Hyuk Soon Choi, Hyunggin An, Hyun Gil Goh, Hyung Joon Yim, Ji Hoon Kim, Jong Eun Yeon, Kwan Soo Byun, Sang Jun Suh, Soon Ho Um, Sung Bum Cho, Tae Hyung Kim, Yeon Seok Seo, Yoon Tae Jeen, Young Kul Jung, Young-Sun Lee거트앤리버 소화기연관학회협의회 · Gut and Liver2020 · 제14권 제1호Clinical features and outcomes of gastric variceal bleeding: retrospective Korean multicenter data고문수, 권소영, 김동준, 김문영, 김병석, 김병호, 김상균, 김영석, 김진동, 김태엽, 김태효, 박성재, 박수영, 박승하, 백순구, 서연석, 손주현, 심재준, 엄순호, 이정일, 이준성, 이진우, 이창형, 이태희, 이현웅, 임영석, 장병국, 장재영, 정승원, 조용균, 조은영, 천갑진, 최원혁, 최창수, 한상영, 황재석대한간학회 · Clinical and Molecular Hepatology2013 · 제19권 제1호The comparison of esophageal variceal ligation plus propranolol versus propranolol alone for the primary prophylaxis of esophageal variceal bleedi고광철, 곽금연, 백승운, 백용한, 유병철, 이준혁, 제동모, 최문석대한간학회 · Clinical and Molecular Hepatology2014 · 제20권 제3호

이 간행물의 다른 논문 (10건)

A systematic approach for the diagnosis and treatment of idiopathic peptic ulcersChen-Shuan Chung, Yi-Chia Lee, Tsung-Hsien Chiangpp. 559-570Oral udenafil and aceclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a randomized multicenter study도재혁, 오형철, 송태준, 천영국, 이태윤, 최정식pp. 602-609Chronic obstructive pulmonary disease (COPD) assessment test scores corresponding to modified Medical Research Council grades among COPD patients유철규, 김영환, 이진우, 한성구, 박영식, 이상민, 임재준, 이창훈pp. 629-637Blood electrolyte disturbances during severe hypoglycemia in Korean patients with type 2 diabetes강미연pp. 648-656The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in Korea김철수, 윤덕현, 이제중, 도영록, 문영철, 조재철, 민창기, 엄현석, 신호진, 이호섭, 박용, 김기현, 이지현, 이완식, 이혜원pp. 675-683
원문 보기